不同肠内营养输注方式对ICU重症患者营养耐受情况的影响

Effects of Different Enteral Nutrition Infusion Methods on Nutritional Tolerance in Severe ICU Patients

目的观察实施不同肠内营养输注方式对ICU重症患者营养耐受情况的影响。方法选取2018年7月—2019年10月本院ICU收治的100例重症患者作为研究对象,以不同肠内营养输注方式作为分组依据,将其分为对照组和试验组,每组50例,对照组采用持续24 h泵入输注方式,试验组采用间断24 h泵入输注方式,对比两组患者治疗后的血清总蛋白、急性生理与慢性健康评分(acute physiology and chronic health evaluation,APACHE-Ⅱ)及不良反应发生率。结果治疗后,试验组血清总蛋白水平为(56.21±5.30)g/L,高于对照组的(52.15±4.71)g/L,APACHE-Ⅱ评分为(18.55±2.61)分,低于对照组的(20.10±2.85)分,比较差异均有统计学意义(t=4.049、2.836,P <0.05);试验组不良反应发生率(8.00%)低于对照组(26.00%),比较差异有统计学意义(χ^(2)=5.740 6,P=0.016 6)。结论 ICU重症患者采用间断24 h泵入输注方式进行肠内营养支持,可有效提高患者血清总蛋白水平,降低不良反应发生率,促进患者康复,值得临床推广。

Objective To observe the effect of different enteral nutrition infusion methods on the nutritional tolerance of critically ill patients in ICU.Methods A total of 100 critically ill patients admitted to the ICU of our hospital from July 2018 to October 2019 were selected as the research objects,and different enteral nutrition infusion methods were used as the grouping basis.They were divided into control group and test group,with 50 cases in each group.The control group was given continuous 24-hour pump infusion,and the test group was given intermittent 24-hour pump infusion.The serum total protein,acute physiology and chronic health evaluation(APACHE-Ⅱ)and the incidence of adverse reactions were compared between the two groups.Results After treatment,the total protein of the test group was(56.21±5.30)g/L,which was higher than(52.15±4.71)g/L of the control group,and the APACHE-Ⅱscore was(18.55±2.61)points,which was lower than(20.10±2.85)points of the control group,the differences were statistically significant(t=4.049,2.836,P<0.05).The adverse reaction rate(8.00%)of the test group was lower than that of the control group(26.00%),and the difference was statistically significant(χ^(2)=5.7406,P=0.0166).Conclusion The use of intermittent 24-hour pump infusion for enteral nutrition support in ICU critically ill patients can effectively increase the serum total protein level of patients,reduce the incidence of adverse reactions,and promote patient recovery.It is worthy of clinical promotion.